Skadden advised Eyebiotech Limited, while Gibson, Dunn & Crutcher advised Merck the deal. Merck, known as MSD outside of the United States and Canada, and Eyebiotech...
Merck’s Acquisition of Eyebiotech
Emtec’s Acquisition of Folcode
Beccar Varela and Gibson Dunn & Crutcher advised Bridgenext, while DLA Piper Argentina advised Folcode on the deal. Folcode, a boutique digital engineering services company based...
XOMA’s $8 Million Acquisition of DSUVIA
Gibson, Dunn & Crutcher LLP advised XOMA Corporation on the expansion of its commercial royalty and milestone portfolio with the acquisition of an economic interest in...
United Therapeutics’ Acquisition of Miromatrix Medical
Gibson, Dunn & Crutcher LLP advised United Therapeutics Corporation on its acquisition of Miromatrix Medical Inc., assisted by Faegre Drinker Biddle & Reath LLP. Piper Sandler...
Neurogene’s Merger with Neoleukin
Gibson Dunn & Crutcher LLP is serving as legal counsel to Neurogene Inc. and Fenwick & West LLP is serving as legal counsel to Neoleukin Therapeutics,...
Assertio Holdings, Inc.’s Acquisition of Spectrum Pharmaceuticals, Inc.
Guggenheim Securities, LLC is acting as financial advisor to Spectrum, and Gibson, Dunn & Crutcher LLP is serving as legal counsel. SVB Securities and H.C. Wainwright...
Natural Balance’s Merger with Canidae
Gibson, Dunn & Crutcher LLP assisted L Catterton on the matter. Natural Balance, a leading premium specialty pet food brand, and Canidae, a premium, sustainable pet...